Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells. (Q40026514)
Jump to navigation
Jump to search
scientific article published on 10 January 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells. |
scientific article published on 10 January 2008 |
Statements
Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells (English)
Clara Lemos
Christina Tekle
Kees Smid
Simona Ricciardi
Godefridus J Peters
10 January 2008